Gateway Pundit | By Jim Hoft Published February 10, 2023 at 8:00am
For the first time, the ‘unsafe and ineffective’ COVID-19 vaccine was formally added to the routine immunization schedule for both children and adolescents by the Centers for Disease Control and Prevention (CDC) on Thursday.
It is common knowledge that COVID-19 poses no threat to young children, that mRNA vaccinations against the virus are not effective or safe and that some people have even died after receiving a COVID vaccine. But the CDC and its advisory council continue to push for childhood vaccinations despite all these facts.
Back in October 2022, the CDC’s Advisory Committee on Immunization Practices (ACIP), which provides advice and guidance to the Director of the CDC regarding the use of vaccines for the control of vaccine-preventable diseases, voted to recommend COVID-19 to be included in the 2023 childhood immunization schedule in 15 unanimous votes.
ACIP recommended the use of COVID-19 vaccines for everyone as young as 6 months and older. The COVID-19 vaccine and other vaccines may be administered on the same day.
Once CDC approves it, our Department of Health can exercise its rule-making authority to add it to the healthcare and school schedule at any time. And now it’s official.
The recommendation to include the experimental COVID vaccine was approved by the CDC together with doctors, nurses, and pharmacists on Thursday as they are bringing the COVID emergency declaration to an end.
“The 2023 child and adolescent immunization schedule, available on the CDC immunization schedule website, summarizes ACIP recommendations, including several changes from the 2022 immunization schedule,” CDC wrote on its website. “Health care providers are advised to use the tables, notes, and appendix together to determine recommended vaccinations for patient populations.”
“This immunization schedule is recommended by ACIP and approved by CDC, the American Academy of Pediatrics, the American Academy of Family Physicians, the American College of Obstetricians and Gynecologists, the American College of Nurse-Midwives, the American Academy of Physician Associates, and the National Association of Pediatric Nurse Practitioners,” CDC added.
The addition of the COVID vaccine gives a more official recommendation to healthcare providers and schools.
“This means COVID-19 vaccine is now presented as any other routinely recommended vaccine and is no longer presented in a special “call out” box as in previous years. This, in a sense, helps ‘normalize’ this vaccine and sends a powerful message to both healthcare providers and the general public that everyone ages 6 months and older should stay up to date with recommended COVID-19 vaccines (including a booster, when eligible), just as they would with any other routinely recommended vaccine,” Dr. Neil Murthy and Dr. A. Patricia Wodi said in a statement.
Routine vaccination of COVID vaccine per CDC:
- Primary series:
- Age 6 months–4 years: 2-dose series at 0, 4-8 weeks (Moderna) or 3-dose series at 0, 3-8, 11-16 weeks (Pfizer-BioNTech)
- Age 5–11 years: 2-dose series at 0, 4-8 weeks (Moderna) or 2-dose series at 0, 3-8 weeks (Pfizer-BioNTech)
- Age 12–18 years: 2-dose series at 0, 4-8 weeks (Moderna) or 2-dose series at 0, 3-8 weeks (Novavax, Pfizer-BioNTech)
- For booster dose recommendations, see www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html
Persons who are moderately or severely immunocompromised:
- Primary series
- Age 6 months–4 years: 3-dose series at 0, 4, 8 weeks (Moderna) or 3-dose series at 0, 3, 11 weeks (Pfizer-BioNTech)
- Age 5–11 years: 3-dose series at 0, 4, 8 weeks (Moderna) or 3-dose series at 0, 3, 7 weeks (Pfizer-BioNTech)
- Age 12–18 years: 3-dose series at 0, 4, 8 weeks (Moderna) or 2-dose series at 0, 3 weeks (Novavax) or 3-dose series at 0, 3, 7 weeks (Pfizer-BioNTech)
- Booster dose: see www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html
- Pre-exposure prophylaxis (monoclonal antibodies) may be considered to complement COVID-19 vaccination. See www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html#immunocompromised
The immunization schedules are updated annually in the late fall and are used as a guideline by states for school entry requirements and by physicians, and healthcare providers.
